Ken Griffin Elanco Animal Health Inc Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 4,843,380 shares of ELAN stock, worth $102 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,843,380
Previous 13,700,781
64.65%
Holding current value
$102 Million
Previous $196 Million
50.14%
% of portfolio
0.02%
Previous 0.04%
Shares
28 transactions
Others Institutions Holding ELAN
# of Institutions
463Shares Held
492MCall Options Held
780KPut Options Held
1.08M-
Dodge & Cox San Francisco, CA82.8MShares$1.75 Billion0.96% of portfolio
-
Primecap Management CO Pasadena, CA50MShares$1.05 Billion0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.6MShares$1.02 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD31.5MShares$665 Million0.39% of portfolio
-
Dimensional Fund Advisors LP Austin, TX24.7MShares$521 Million0.11% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $10B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...